Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 2Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Sarcoma 1Myeloid 1Head & Neck 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 1043Lung Neoplasms 800Small Cell Lung Carcinoma 193Breast Neoplasms 158Colorectal Neoplasms 156Neoplasms 128Melanoma 116Ovarian Neoplasms 111Pancreatic Neoplasms 106Stomach Neoplasms 95Neoplasm Metastasis 88Esophageal Neoplasms 77Squamous Cell Carcinoma of Head and Neck 75Prostatic Neoplasms 66Uterine Cervical Neoplasms 65Head and Neck Neoplasms 65Endometrial Neoplasms 61Triple Negative Breast Neoplasms 59Carcinoma, Renal Cell 58Colonic Neoplasms 57Mesothelioma, Malignant 48Adenocarcinoma of Lung 48Urinary Bladder Neoplasms 47Carcinoma, Hepatocellular 46Mesothelioma 42Sarcoma 40Brain Neoplasms 40Liver Neoplasms 38Disease 34NSCLC 33

Interventions

Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Spinocerebellar Degenerations × Thoracic × Clear all
NCT07540572 2026-05-20

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

IDEAYA Biosciences

Phase 1/2 Recruiting
160 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡